İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

OpenAlex konusu

Berberine and alkaloids research

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 858 eser 14 yazar konusu

Çalışmalar

858 eser

  1. Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids 2011
    OpenAlex üst %10 OpenAlex 98.7%

    OBJECTIVE: Some natural products consisting of the alkaloids yohimbine and vincamine (indole-type), scopolamine and atropine (tropane-type), colchicine (tropolone-type), allantoin (imidazolidine-type), trigonelline (pyridine-type) as well as octopamine, synephrine, and capsaicin (exocyclic amine-type); the flavonoid d…

  2. Cytotoxicity antiviral and antimicrobial activities of alkaloids flavonoids and phenolic acids 2011
    YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 98.7%

    OBJECTIVE: Some natural products consisting of the alkaloids yohimbine and vincamine (indole-type), scopolamine and atropine (tropane-type), colchicine (tropolone-type), allantoin (imidazolidine-type), trigonelline (pyridine-type) as well as octopamine, synephrine, and capsaicin (exocyclic amine-type); the flavonoid d…

  3. Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids 2011
    YÖKSİS OpenAlex üst %10 OpenAlex 98.7%

    OBJECTIVE: Some natural products consisting of the alkaloids yohimbine and vincamine (indole-type), scopolamine and atropine (tropane-type), colchicine (tropolone-type), allantoin (imidazolidine-type), trigonelline (pyridine-type) as well as octopamine, synephrine, and capsaicin (exocyclic amine-type); the flavonoid d…

  4. A comparative study on the anti inflammatory antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species 2002
    YÖKSİS SJR Q1 JCR Q2 OpenAlex 88.8%

    Özet henüz yok.

  5. Berberis crataegina DC root exhibits potent anti inflammatory analgesic and febrifuge effects in mice and rats 2002
    YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 91.4%

    Özet henüz yok.

  6. Addition of thalidomide to oral melphalan prednisone in patients with multiple myeloma not eligible for transplantation results of a randomized trial from the Turkish Myeloma Study Group 2011
    YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.4%

    The combination of melphalan-prednisone-thalidomide (MPT) has been investigated in several clinical studies that differed significantly with regard to patient characteristics and treatment schedules. This prospective trial differs from previous melphalan-prednisone (MP) vs. MPT trials by treatment dosing, duration, ro…

  7. Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group 2011
    YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.4%

    The combination of melphalan-prednisone-thalidomide (MPT) has been investigated in several clinical studies that differed significantly with regard to patient characteristics and treatment schedules. This prospective trial differs from previous melphalan-prednisone (MP) vs. MPT trials by treatment dosing, duration, ro…

  8. Addition of thalidomide to oral melphalan prednisone in patients with multiple myeloma not eligible for transplantation results of a randomized trial from the Turkish Myeloma Study Group 2011
    YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.4%

    The combination of melphalan-prednisone-thalidomide (MPT) has been investigated in several clinical studies that differed significantly with regard to patient characteristics and treatment schedules. This prospective trial differs from previous melphalan-prednisone (MP) vs. MPT trials by treatment dosing, duration, ro…

  9. Addition of thalidomide to oral melphalan prednisone in patients with multiple myeloma not eligible for transplantation results of a randomized trial from the Turkish Myeloma Study Group 2011
    YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.5%

    The combination of melphalan-prednisone-thalidomide (MPT) has been investigated in several clinical studies that differed significantly with regard to patient characteristics and treatment schedules. This prospective trial differs from previous melphalan-prednisone (MP) vs. MPT trials by treatment dosing, duration, ro…

  10. Addition of thalidomide to oral melphalan prednisone in patients with multiple myeloma not eligible for transplantation results of a randomized trial from the Turkish Myeloma Study Group 2011
    YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.5%

    The combination of melphalan-prednisone-thalidomide (MPT) has been investigated in several clinical studies that differed significantly with regard to patient characteristics and treatment schedules. This prospective trial differs from previous melphalan-prednisone (MP) vs. MPT trials by treatment dosing, duration, ro…

  11. Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group 2011
    YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.5%

    The combination of melphalan-prednisone-thalidomide (MPT) has been investigated in several clinical studies that differed significantly with regard to patient characteristics and treatment schedules. This prospective trial differs from previous melphalan-prednisone (MP) vs. MPT trials by treatment dosing, duration, ro…

  12. Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group 2011
    YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.5%

    The combination of melphalan-prednisone-thalidomide (MPT) has been investigated in several clinical studies that differed significantly with regard to patient characteristics and treatment schedules. This prospective trial differs from previous melphalan-prednisone (MP) vs. MPT trials by treatment dosing, duration, ro…

Akademisyenler

14 akademisyen